Search Result "Drug Desensitization"
Desensitization for Drug Hypersensitivity to Chemotherapy and Monoclonal Antibodies
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 45 Year: 2016 Page: 6870-6880
Author(s): Rafael Bonamichi-Santos,Mariana Castells
Rapid Desensitization of Hypersensitivity Reactions to Chemotherapy Agents.
Journal: Current Drug Safety
Volume: 1 Issue: 3 Year: 2006 Page: 243-251
Author(s): Mariana Castells
Clopidogrel Desensitization: Background and Recommendations for Use of a Rapid (4 Hour) Protocol
Journal: Current Vascular Pharmacology
Volume: 17 Issue: 2 Year: 2019 Page: 113-118
Author(s): Jeffrey Bulva,Ronald A. Simon
Desensitization Protocol for Rituximab-Induced Serum Sickness
Journal: Current Drug Safety
Volume: 9 Issue: 3 Year: 2014 Page: 240-242
Author(s): Merritt L. Fajt,Andrej A. Petrov
A “Cute” Desensitization of TRPV1
Journal: Current Pharmaceutical Biotechnology
Volume: 12 Issue: 1 Year: 2011 Page: 122-129
Author(s): Filip Touska, Lenka Marsakova, Jan Teisinger, Viktorie Vlachova
Successful Desensitization of Three Patients with Hypersensitivity Reactions to Omalizumab
Journal: Current Drug Safety
Volume: 6 Issue: 5 Year: 2011 Page: 339-342
Author(s): Gregory Owens, Andrej Petrov
A Safe and Novel Desensitization Protocol with Ferric Carboxymaltose to Treat Iron Deficiency Anemia
Journal: Current Drug Safety
Volume: 11 Issue: 2 Year: 2016 Page: 145-148
Author(s): Shari V. Montandon, Merritt L. Fajt, Andrej A. Petrov
A Novel Desensitization Protocol for Infliximab Hypersensitivity in a 13-Year Old Patient with Pustular Psoriasis
Journal: Current Drug Safety
Volume: 14 Issue: 2 Year: 2019 Page: 158-162
Author(s): Sapan Kumar Behera,Sandhiya Selvarajan,Jerene Mathews,Chandana Shajil,Saibal Das,Malathi Munisamy,Alphienes Stanley Xavier
Agonist-Regulated Internalization and Desensitization of the Human Nociceptin Receptor Expressed in CHO Cells
Journal: Current Drug Targets
Volume: 8 Issue: 1 Year: 2007 Page: 137-146
Author(s): S. Spampinato, M. Baiula, M. Calienni
Hypersensitivity to Febuxostat in a Patient with a Previous AllopurinolinducedSteven-Johnson Syndrome: A Case Report of Treatment with aSlow Desensitization Protocol
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 22 Issue: 8 Year: 2022 Page: 895-899
Author(s):